» Authors » Elena Oliva

Elena Oliva

Explore the profile of Elena Oliva including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 9
Citations 232
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Calatroni M, Consonni F, Allinovi M, Bettiol A, Jawa N, Fiasella S, et al.
Clin J Am Soc Nephrol . 2021 May; 16(7):1043-1051. PMID: 34039568
Background And Objectives: ANCA-associated vasculitis is extremely rare in children. We report the clinicopathologic features, long-term outcomes, and prognostic factors of a large pediatric cohort of patients with ANCA-associated kidney...
2.
Maritati F, Alberici F, Oliva E, Urban M, Palmisano A, Santarsia F, et al.
PLoS One . 2017 Oct; 12(10):e0185880. PMID: 29016646
Objectives: The treatment of anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis (AAV) is based on remission-induction and remission-maintenance. Methotrexate is a widely used immunosuppressant but only a few studies explored its role...
3.
Calatroni M, Oliva E, Gianfreda D, Gregorini G, Allinovi M, Ramirez G, et al.
Ital J Pediatr . 2017 May; 43(1):46. PMID: 28476172
Anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitides are rare systemic diseases that usually occur in adulthood. They comprise granulomatosis with polyangiitis (GPA, Wegener's), microscopic polyangiitis (MPA) and eosinophilic granulomatosis with polyangiitis (EGPA,...
4.
Gioffredi A, Maritati F, Oliva E, Buzio C
Front Immunol . 2014 Nov; 5:549. PMID: 25404930
Eosinophilic granulomatosis with polyangiitis (EGPA) is a multisystemic disorder, belonging to the small vessel anti-neutrophil cytoplasmic antibody (ANCA)-associated vasculitis, defined as an eosinophil-rich and necrotizing granulomatous inflammation often involving the...
5.
Passalacqua R, Caminiti C, Buti S, Porta C, Camisa R, Braglia L, et al.
J Immunother . 2014 Oct; 37(9):440-7. PMID: 25304727
There is currently no standard therapy to reduce the recurrence rate after surgery for renal cell carcinoma (RCC). The aim of this study was to assess efficacy and safety of...
6.
Alberici F, Palmisano A, Urban M, Maritati F, Oliva E, Manenti L, et al.
Ann Rheum Dis . 2013 May; 72(9):1584-6. PMID: 23696631
No abstract available.
7.
Clavo B, Ceballos D, Gutierrez D, Rovira G, Suarez G, Lopez L, et al.
J Pain Symptom Manage . 2012 Oct; 46(1):106-12. PMID: 23102757
Context: Persistent or severe hemorrhagic radiation proctitis (HRP) has limited therapeutic options. Objectives: To describe our experience with ozone therapy (O3T) in the management of refractory HRP. Methods: Patients (n=17;...
8.
Martorana D, Maritati F, Malerba G, Bonatti F, Alberici F, Oliva E, et al.
Rheumatology (Oxford) . 2012 Jan; 51(5):805-12. PMID: 22237046
Objectives: PTPN22 is involved in T-cell activation and its R620W single-nucleotide polymorphism (SNP) has been shown to predispose to different autoimmune diseases. The aims of this study were to investigate...
9.
Buzio C, Oliva E
Rheumatology (Oxford) . 2011 Feb; 50(10):1737-8. PMID: 21292740
No abstract available.